Kayne Anderson Rudnick Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-200
Closed -$20.3K 985
2025
Q4
$20.3K Hold
200
﹤0.01% 663
2025
Q3
$10.9K Sell
200
-4
-2% -$200 ﹤0.01% 708
2025
Q2
$10.8K Buy
204
+4
+2% +$203 ﹤0.01% 712
2025
Q1
$8.66K Hold
200
﹤0.01% 698
2024
Q4
$11.2K Hold
200
﹤0.01% 675
2024
Q3
$13.6K Hold
200
﹤0.01% 643
2024
Q2
$8.45K Hold
200
﹤0.01% 645
2024
Q1
$13.8K Hold
200
﹤0.01% 609
2023
Q4
$14.8K Hold
200
﹤0.01% 595
2023
Q3
$13.7K Buy
+200
New +$17K ﹤0.01% 574
2023
Q2
Hold
0
874
2021
Q1
Sell
-9
Closed -$1K 614
2020
Q4
$1K Buy
+9
New +$1.09K ﹤0.01% 604
2020
Q2
Sell
-365
Closed -$21K 569
2020
Q1
$21K Buy
365
+350
+2,333% +$28.4K ﹤0.01% 422
2019
Q4
$1K Hold
15
﹤0.01% 615
2019
Q3
$1K Buy
+15
New +$1.71K ﹤0.01% 540

Other funds holding EXAS

Kayne Anderson Rudnick Investment Management's EXAS Position: Q1 2026 in Review

Kayne Anderson Rudnick Investment Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 200 shares — an estimated $20.3K sold.

Kayne Anderson Rudnick Investment Management first reported a position in EXAS in Q3 2019 and held it in 14 quarters. The position peaked at $21K in Q1 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Kayne Anderson Rudnick Investment Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 200 Exact Sciences shares in Q1 2026, an estimated $20.3K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Exact Sciences in Q3 2019 and held it in 14 quarters.
  • Kayne Anderson Rudnick Investment Management's Exact Sciences position peaked at $21K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.